HA Sustainable Infrastructure Capital (NYSE:HASI – Free Report) had its price target upped by JPMorgan Chase & Co. from $50.00 to $51.00 in a report released on Friday,Benzinga reports. The brokerage currently has an overweight rating on the real estate investment trust’s stock. Several other research analysts also recently weighed in on the stock. Royal […]
| # | Наименование новости | Тональность | Информативность | Дата публикации |
|---|---|---|---|---|
| 1 | Haemonetics (NYSE:HAE) Price Target Raised to $86.00 | 0 | 14.69 | 10-08-2026 |
| 2 | Royalty Pharma (NASDAQ:RPRX) Price Target Raised to $62.00 | 0 | 13.82 | 10-08-2026 |
| 3 | CACI International (NYSE:CACI) Price Target Raised to $715.00 | 0 | 14.65 | 10-08-2026 |
| 4 | Cadre (NYSE:CDRE) Price Target Raised to $45.00 | 0 | 13.85 | 10-08-2026 |
| 5 | Target (NYSE:TGT) Price Target Raised to $157.00 | 0 | 13.85 | 10-08-2026 |
| 6 | Genpact (NYSE:G) Price Target Raised to $45.00 | 0 | 14.26 | 10-08-2026 |
| 7 | TG Therapeutics (NASDAQ:TGTX) Price Target Raised to $72.00 | 0 | 13.04 | 10-08-2026 |
| 8 | Qiagen (NYSE:QGEN) Price Target Raised to $50.00 | 0 | 14.26 | 10-08-2026 |
| 9 | JFrog (NASDAQ:FROG) Price Target Raised to $115.00 | 0 | 14.6 | 10-08-2026 |
| 10 | Banco De Chile (NYSE:BCH) Price Target Raised to $45.00 | 0 | 14.2 | 10-08-2026 |